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The working hypothesis of guided bone regeneration (GBR) is that the membrane physically excludes
non-osteogenic tissues from interfering with bone healing. However, the underlying mechanisms are
insufﬁciently explained. This study aimed to investigate the molecular and structural pattern of bone
healing in trabecular bone defects, with and without naturally derived resorbable membrane. Defects
were created in rat femurs and treated with the membrane or left empty (sham). After 3d, 6d and 28d,
the defect sites and membranes were harvested and analyzed with histology, histomorphometry,
quantitative-polymerase chain reaction (qPCR), Western blot (WB) and immunohistochemistry (IHC).
Histomorphometry demonstrated that the presence of the membrane promoted bone formation in early
and late periods. This was in parallel with upregulation of cell recruitment and coupled bone remodeling
genes in the defect. Cells recruited into the membrane expressed signals for bone regeneration (BMP-2,
FGF-2, TGF-b1 and VEGF). Whereas the native membrane contained FGF-2 but not BMP-2, an accumu-
lation of FGF-2 and BMP-2 proteins and immunoreactive cells were demonstrated by WB and IHC in the
in vivo implanted membrane. The results provide cellular and molecular evidence suggesting a novel role
for the membrane during GBR, by acting as a bioactive compartment rather than a passive barrier.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Guided bone regeneration (GBR) is an established treatment
modality to achieve bone regeneration, especially in the maxillo-
facial region. GBR treatment is based on the application of a barrier
membrane to cover an osseous defect. The concept of GBR was
developed on the hypothesis that the membrane excludes non-
osteogenic tissues from interfering with bone healing for efﬁcient
bone formation [1,2]. Although the GBR concept is generally
accepted, the underlying biological mechanisms are as yet insufﬁ-
ciently explained.
The ﬁrst generation of the barrier membrane comprised non-als, Institute of Clinical Sci-
enburg, Box 412, SE-405 30,
(P. Thomsen).
Ltd. This is an open access article uresorbable materials, e.g. expanded polytetraﬂuoroethylene (e-
PTFE). This type of membrane has shown good biocompatibility
and the maintenance of structural integrity during healing. The
non-resorbable membranes have generally shown positive results
when investigated in experimental studies and when used in
clinical GBR procedures [3,4]. However, the need for additional
surgery, for the removal of the membrane, has been regarded as a
disadvantage [5]. A second generation of resorbable, natural or
synthetic, membranes has therefore been introduced, aiming to
eliminate the need for the second surgical procedure.
Naturally derived collagen membranes have attracted a great
deal of attention, since collagen is a principal component of con-
nective tissue andmay provide structural support. As a biomaterial,
collagen has a number of properties, including resorbability and
low immunogenicity [6]. Although some clinical reviews have
indicated comparable clinical outcomes between collagen mem-
branes and non-resorbable membranes [7,8], other studies have
suggested that the collagen membranes may promote even betternder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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collagen-based membrane derived from the extracellular matrix
(ECM) of the porcine small intestinal submucosa [9]. This mem-
brane consists of approximately 90% collagen (mainly Type I) [9],
with smaller amounts of glycosaminoglycans [10], glycoproteins
and some growth factors [11]. Experimental studies have suggested
that this ECM material may inﬂuence the regenerative capacity of
the host and repair in several tissues and organs, including the
urinary bladder [12], the abdominal wall [13], tendon [14], blood
vessels [15], articular cartilage [16] and bone [17]. Nevertheless, the
underlying mechanisms explaining how the ECM-derived collagen
membrane promotes tissue regeneration are largely unknown.
The main questions to be addressed in this study are: (i) Does
the presence of a collagenous membrane modulate the expression
of factors crucial for inﬂammation, bone formation and remodeling
in an underlying bone defect? (ii) Does the membrane host cells,
which express factors crucial for bone regeneration? (iii) Is the
expression of these factors in the membrane related to the mo-
lecular and structural development of the bone in the defect?
Using a rat experimental model, the present study employed a
set of correlative analytical techniques (histology, histo-
morphometry, quantitative-polymerase chain reaction (qPCR),
Western blot and immunohistochemistry) to determine whether
the membrane acts as a bioactive compartment, in contrast to the
prevailing view that a membrane used for guided bone regenera-
tion mainly serves as a passive barrier.
2. Materials and methods
2.1. Material
The extracellular matrix membrane used in this study was
extracted from porcine small intestine (DynaMatrix®; Keystone
Dental, Boston, USA).
2.2. Scanning electron microscopy analysis of the membrane
The native membrane was cut into 5  5 mm pieces and soaked
in 1% osmium tetroxide (OsO4) solution for 2 h at 4 C. The samples
were rinsed twice with 0.3% sodium cacodylate buffer and were
allowed to air-dry for 24 h. The samples were gold (Au) sputter
coated (approximately 10 nm) from both sides. Scanning electron
microscopy was performed at high-vacuum, 5 kV accelerating
voltage and 5e10 mm working distance in the secondary electron
mode (Ultra 55 FEG SEM; Leo Electron Microscopy Ltd, UK). The
SEM characterization of the membrane is presented in (Fig. 1AeG).
2.3. Animal surgery
The animal experiments were approved by the Local Ethics
Committee for Laboratory Animals at the University of Gothenburg
(dnr 279/2011). A total of 52 male SpragueeDawley rats were used
for the in vivo experiments. The animals were anesthetized using
isoﬂurane (Isoba Vet, Schering-Plough, Uxbridge, UK) gas inhala-
tion with the Univentor 400 anesthesia unit (Univentor, Zejtun,
Malta). Anesthesia was maintained by the continuous administra-
tion of isoﬂurane via a mask. The surgical site was shaved and
cleaned with 5 mg/mL chlorhexidine and 70% ethanol. A linear
incisionwasmade at the distal aspect of the femur, followed by skin
and periosteal reﬂection. Bilateral femoral defects were created in
each animal. A defect was created in each femoral epiphysis
(trabecular bone region) using a trephine with a 2.3 mm internal
diameter and 2.5 mm penetration depth under generous irrigation
with NaCl 0.9%. The bone harvested from the defect site was
collected from the trephine and preserved for the determination ofsteady-state gene expression (baseline (BL); n ¼ 8). One defect was
covered with a membrane and the other defect was left uncovered
(Fig. 1H, I). The subcutaneous and skin layers were closed, using
resorbable polyglactin (Vicryl, 4-0; Ethicon, USA) and resorbable
Monocryl (4-0; Ethicon, USA) sutures respectively. The retrieval
procedure was performed at 3d, 6d and 28d (16 rats at each time
point), when the animals were sacriﬁced using an overdose of
barbiturate (Mebumal, ACO L€akemedel AB, Solna, Sweden). The
retrieval procedure was chosen depending on the subsequent
analytical technique (Fig. 1J, K). For histology and histo-
morphometry at 6d and 28d (n ¼ 8), the skin was carefully reop-
ened and the bone defect site with the overlying membrane and
soft tissue were harvested en bloc and preserved in formalin. For
gene expression and Western blot protein analyses at 3d, 6d and
28d (n ¼ 8), the skin and soft tissues were carefully reopened and
the membrane was gently retrieved using tweezers. Subsequently,
the defect site was retrieved using a 2.3 mm trephine. The mem-
brane and the defect tissue samples were immediately and sepa-
rately preserved in tubes containing RNAlater solution. For
immunohistochemistry at 3d and 6d (n ¼ 6), the skin was carefully
reopened and the bone defect site with the overlying membrane
and soft tissue were harvested en bloc and preserved in formalin.
2.4. Histology and histomorphometry
The formalin-ﬁxed blocks were dehydrated by a graded series of
ethanol and embedded in acrylic resin (LR White) (London Resin
Company Ltd, Berkshire, UK). The long axis of the defect was cut
using a diamond saw. Ground sections were prepared using sawing
and grinding (Exakt Apparatebau GmbH & Co, Norderstedt, Ger-
many), according to a previously published protocol [18]. Sections
with a ﬁnal thickness of 10e20 mmwere stained with 1% toluidine
blue. All sections were coded and evaluated blindly for histology
and histomorphometry using a light microscope (Nikon Eclipse
E600). Histomorphometry was performed on each section using a
10 objective. In each defect, the area percentages of newly formed
bone were calculated. The measurements were performed on the
total defect area level and by dividing the total defect area into top,
middle and bottom regions or central and peripheral regions. This
was achieved by performing the measurements using a software
grid consisting of twelve zones, which covered the total area of the
defect. The top region was the area close to the membrane and was
represented by the sum of the top four zones of the grid. Each of the
middle and bottom regions also consisted of four zones. Further-
more, the total area of the zones adjacent to the old bone was
regarded as the peripheral region of the defect, whereas the central
region was the sum of the remaining zones. The area of newly
formed bonewas determined separately in every zone and the area
percentage of bone was then calculated with respect to the total
defect area or to the area of the respective region.
2.5. Homogenization and total RNA extraction from the defect
samples
Total RNA from the defect site samples was extracted using an
RNeasy® Mini kit (QIAGEN GmbH, Hilden, Germany). The homog-
enization was performed in phenol/guanidine-based trizol lysis
(QIAGEN GmbH, Hilden, Germany) using a 5 mm stainless steel
bead (QIAGEN GmbH, Hilden, Germany) and Tissue Lyser (QIAGEN
GmbH, Hilden, Germany). Subsequently, the aqueous phase was
used for RNA extraction. The phase separation was performed by
the addition of chloroform, followed by centrifugation at 12,000 g
for 15 min. To reduce genomic DNA contamination, all samples
were DNase treated with an RNase-free DNase during RNA
extraction. The RNA quality was analyzedwith a Nano 6000 RNA kit
Fig. 1. Scanning electron microscopy (SEM) analysis of the native membrane and the surgical schedule. The SEM micrographs show the rough (A) and the smooth surfaces (B) of the
membrane taken at a 30 tilt. The rough surface displays gross undulations and a ﬁbrous texture (C, D). The smooth surface has a less exaggerated topography (E, F). Well-preserved,
discrete layers are observed in cross-section (G). The micrographs (H and I) show the prepared defect (sham; H) and the prepared defect with the membrane (membrane; I). The
schedules (J and K) illustrate the different tissue components for the sham defect (J) and the defect covered with the membrane (K). The small letters indicate the different
components allocated to the different analyses: a ¼ the defect site dissected en bloc, with surrounding tissue, for histology and histomorphometry analysis; b ¼ the defect site
retrieved by trephine for gene expression (qPCR) analysis; c ¼ the membrane retrieved gently by tweezers for gene expression (qPCR) and protein (WB) analyses.
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nologies; Santa Clara, CA, USA). The RNA concentration was
measured using a Nanophotometer P-36 (Implen GmbH, Munich,
Germany).
2.6. Homogenization and total RNA and protein extraction from the
membrane samples
For total protein and RNA extraction from the retrieved mem-
brane samples, a NucleoSpin RNA/protein isolation kit (Macher-
eyeNagel, Germany) was used. A similar procedure was used to
extract total protein from native, unimplanted membrane samples
(n ¼ 8). Prior to extraction, all samples were homogenized. The
homogenization and the lysis of the membrane samples was per-
formed in guanidinium thiocyanate lysis buffer (MachereyeNagel,Germany), using a 5 mm stainless steel bead (QIAGEN GmbH, Hil-
den, Germany) and Tissue Lyser (QIAGEN GmbH, Hilden, Germany).
To reduce viscosity and clear the lysate, the lysate was ﬁltrated
through NucleoSpin® (MachereyeNagel, Germany) in collection
tubes and centrifuged for 1min at 11,000 g. Thereafter, NucleoSpin®
RNA/Protein columns (MachereyeNagel, Germany) were placed in
new collection tubes and loaded with the lysate, followed by
centrifugation for 30 s at 11,000 g. At this step, the total RNA was
bound to the column membrane, which was then puriﬁed using
DNA digestion kit (MachereyeNagel, Germany) and subsequently
used for reverse transcription and qPCR analysis (as described
below). The total protein, contained in the ﬂow-through in the
collection tubes, was then precipitated, washed in ethanol and
dried at room temperature, and was then used for Western blot
analysis (as described below).
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Before reverse transcription, the total RNA extracted from the
defect site and membrane samples was normalized to 20 ng/ml. All
reverse transcriptions were performed using a GrandScript cDNA
Synthesis Kit (TATAA Biocenter, Sweden). In order to select the
most stable reference genes for normalization, a panel of nine
reference genes was screened in ﬁve samples from the retrieved
tissue, as well as from the retrieved membrane at each time period.
The expression proﬁles of the screened reference genes were
evaluated using geNorm [19] and Normﬁnder [20] software. The
most stable expression was achieved by HPRT1, GAPDH and ACTB,
which were selected as reference genes for the present analysis.
The design of primers for ﬁfteen target genes of interest was per-
formed using Primer3 web-based software. The assays were pur-
chased from TATAA Biocenter AB, Gothenburg, Sweden. The target
genes analyzed in the defect site samples were: tumor necrosis
factor alpha (TNF-a), interleukin-6 (IL-6), chemokine receptor type
4 (CXCR4), monocyte chemoattractant protein-1 (MCP-1), alkaline
phosphatase (ALP), osteocalcin (OC), calcitonin receptor (CR),
cathepsin K (CatK), receptor activator of NF-kappa B ligand
(RANKL), osteoprotegerin (OPG) and receptor activator of NF-kappa
B (RANK). The target genes analyzed in the retrieved membrane
samples were bone morphogenetic protein 2 (BMP-2), ﬁbroblast
growth factor (FGF-2), transforming growth factor beta1 (TGF-b1)
and vascular endothelial growth factor (VEGF). The analysis of the
target genes and the best three selected reference genes was per-
formed in a 10 ml reaction volume in duplicate on a CFX 96 Real time
System (Bio-Rad Laboratories, Inc., California, USA) with Grand-
master SYBR mix (TATAA Biocenter, Gothenburg, Sweden). An
Inter-plate Calibrator was used to compensate for the variation
between runs. Quantities of the target genes were normalized us-
ing the geometric mean of the Cq values of the selected reference
genes. The normalized relative quantities were calculated using the
deltaedelta Cq method and 90% PCR efﬁciency (k*1.9DDct) [21].
2.8. Western blot
Firstly, the total protein concentration (from native and
retrieved membranes) was determined using a BCA protein assay
kit (Pierce, Thermo Scientiﬁc, USA). Fifty mg from the protein extract
of the native and the retrieved membrane samples was prepared in
Laemmli sample buffer (Bio-Rad Laboratories, Inc., California, USA).
The samples were heated at 95 C for 5 min, cooled instantly and
loaded onto a 10% TGX protean precast gel (Bio-Rad Laboratories,
Inc., California, USA) for gel electrophoresis. The separated protein
bands were transferred from the gel to a nitrocellulose membrane
(Bio-Rad Laboratories, Inc., California, USA). The non-speciﬁc
binding sites were blocked by rinsing the nitrocellulose mem-
brane with Tris-Buffered Saline-Tween (TBST) containing 2% non-
fat skimmed milk powder for 90 min at room temperature. Blots
were then probed, overnight at 4 C, with the following primary
antibodies: rabbit polyclonal anti-BMP-2 (1:1000 dilutions)
(18933-1-AP, Proteintech Group, Inc., USA) and rabbit polyclonal
anti-FGF-2 (1:500 dilutions) (antibodies-online GmbH, Aachen,
Germany), followed by rinsing with TBST 3  5 min. As the native
membrane is obtained from the small intestinal submucosa of the
pig, the primary antibodies were selected with respect to species
reactivity for both rats and pigs. Protein from rat liver was used as a
positive control for BMP-2 antibody. The blots were then incubated
with the appropriate horseradish-peroxidase secondary goat anti-
rabbit antibody (Santa Cruz Biotechnology, Inc., Texas, USA) at a
dilution of 1:10,000 for 1 h at room temperature. All antibodies
were diluted in 2% non-fat skimmed milk powder in TBST. Finally,
the blots were washed 5  10 min in TBST. Band detection wasperformed using the Chemiluminiscence with Clarity TM Western
ECL Substrate detection kit (Bio-Rad Laboratories, Inc., USA). The
ChemiDoc XRS þ system with Image Lab Software (Bio-Rad Labo-
ratories, Inc., California, USA) was used for digital visualization.
2.9. Immunohistochemistry
After ﬁxation in formalin, the dissected blocks were decalciﬁed,
for 10 days, in a 10% EDTA and subsequently embedded in parafﬁn.
3-5-mm-thick sections were obtained using microtome and
mounted on poly-L-lysine slides (Menzel GmbH and Co KG,
Braunschweig, Germany). After deparafﬁnization, the sections were
hydrated and incubated with either primary rabbit anti-rat BMP-2
polyclonal antibody (18933-1-AP, Proteintech Group, Inc., USA) or
primary rabbit anti-rat FGF-2 polyclonal antibody (ABIN1582147,
antibodies-online GmbH, Germany). To exclude false positive
reactivity, negative control slides were prepared using the same
protocol but with the omission of the primary antibody and the
incubationwith 1% BSA in PBS. The immunoreactivity of BMP-2 and
FGF-2 was detected and visualized using goat anti-rabbit IgG sec-
ondary antibody with horseradish peroxidase (HRP) (sc-2004,
Santa Cruz Biotechnology, USA) and Betazoid DAB Chromogen kit
(Biocare Medical, USA). The qualitative analysis was performed
using a light microscope (Nikon Eclipse E600) (objectives x20 and
x40).
2.10. Statistics
For histomorphometry and gene expression analyses, compari-
sons were made between the sham and the membrane groups and
between the different time periods for each group (n ¼ 8). In
addition, the statistical differences between the steady state
(baseline (BL); n¼ 8) and the different time points were calculated.
A non-parametric Wilcoxon's signed rank test was used to identify
differences between the sham and membrane groups, while a non-
parametric KruskaleWallis test followed by a ManneWhitney test
were used to identify statistical differences between the time BL
and the different time points. In addition, Spearman's correlation
analysis was performed on the expression levels of the analyzed
genes in the defect, with and without membrane, after 3d, 6d and
28d. The correlation analysis was also performed on the different
analyzed genes in the membrane, as well as on the genes in the
membrane versus the genes in the equivalent defect samples after
pooling the expression levels for all healing time periods (3d, 6d
and 28d). All analyses were performed using SPSS Version 10
software (SPSS, Inc., New York, USA). The signiﬁcance level was set
at 0.05 for the comparative analyses and at 0.01 for the correlative
analyses.
3. Results
3.1. Macroscopic observations
Macroscopic observations during retrieval surgery showed that
the sites had healed uneventfully, with no visual manifestations of
surgical complications or inﬂammation during the experimental
period. At 28d, whereas the defect margins could still be identiﬁed
in the sham group (Fig. 2A), the union of the defect margins was
observed in the membrane group (Fig. 2B).
3.2. Histology and histomorphometry of the defect site
At 6d, the histological examination revealed a well-deﬁned
defect with clear borders in trabecular bone. The implanted
membrane appeared beneath the soft tissue, overlying the created
Fig. 2. Macroscopic observations after 28d of healing. The micrographs show the defect sites after 28d of healing in the sham defect (A) and in the membrane defect (B), after the
dissection of the soft tissue and the removal of the membrane. In the sham group, the defect is not fully restituted, as the defect boundaries can still be observed and the entrapment
of soft tissue in the defect is frequently encountered.
Fig. 3. Histology of the defects. The micrographs show non-decalciﬁed toluidine blue-stained ground sections of femur defects after 6d (AeH) and 28d (IeP) of healing. The defects
are sham (AeD and IeL) or covered with membrane (EeH and MP). The membrane (m) appears underneath the soft tissue (ST), covering the defect (d). The new bone (NB) formed
at 6d is primarily localized in the bottom peripheral regions in both defects. In the membrane-treated defect, more islands of NB are also observed in the top region of the defect
under the membrane. At 28d, a lower proportion of NB is observed in the sham defects compared with the membrane defects. The amount of NB is apparently higher in the top-
peripheral and top-central regions of the membrane defects compared with the equivalent regions in the sham defects. The ST occupies a large proportion of the defect area in the
sham group.
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A. Turri et al. / Biomaterials 84 (2016) 167e183172defect (Fig. 3). No major inﬂammatory inﬁltrates were detected in
the defect, in either the sham or the membrane groups. Moreover,
signs of intramembranous osteogenesis were observed, with the
formation of osteoid tissue and new bone in both defects (Fig. 3A,
E). A large proportion of newly formed bone, extending from the
old bone, was observed at the bottom of the defect. In addition,
solitary islands of new bone were detected along the peripheral
boundaries of both defects. In the membrane-treated defect, more
islands of newly formed (woven) bone were observed in the top
region of the defect under the membrane (Fig. 3F, G).
Histomorphometry of the defects at 6d showed that the per-
centage of total area of new bone was approximately 8.6%, in both
the sham and themembrane groups (Fig. 4A). A signiﬁcantly higher
proportion of newly formed bone was detected in the top level of
the membrane-treated defect (3.2 ± 0.7) compared with the top
level in the sham defect (1.4 ± 0.4) (Fig. 4C). Otherwise, no major
differences in new bone formation between the membrane-treated
and sham defects were found, in either the middle and bottom
levels, or in the central or the peripheral regions (Fig. 4B, C).
At 28d, a substantial amount of bone had formed in both defects
(Fig. 3I, M), especially in themembrane group (Fig. 3M). The bone at
this time point appearedmature andwell mineralized, as judged by
the toluidine blue staining showing comparable intensity between
the old and new bone (Fig. 3J, N). One major observation at this late
time point was the level of defect restitution and the amount of
bone formation. The sham defect showed fewer bone trabeculae of
mature bone, bordered endosteally by the bone marrow and peri-
osteally by the overlying soft tissue. In addition, the contour of the
original bone in the sham defects was not restored and soft tissue
ingrowth was apparently observed inside the defect (Fig. 3IeL). In
contrast, the membrane-treated defect revealed a larger amount of
mature bone, as well as a higher degree of defect restitution after
28d (Fig. 3MeP).
Histomorphometry revealed two major differences between the
sham and the membrane-treated defects at 28d. Firstly, the per-
centage of total bone areawas signiﬁcantly higher in themembrane
group (28 ± 1.7) compared with the sham group (25 ± 1.2) (Fig. 4A).
Secondly, a signiﬁcantly higher proportion of bone was detected at
the top level (39.8 ± 4.8), as well as in the central region (23.6 ± 3.1)
of the membrane defect, compared with the top level (27.4 ± 2.1)
and the central region (16.5 ± 2.5) of the sham defect (Fig. 4B, C).
Temporally, from 6d to 28d, themeasurement of bone formation
at the different topological levels of the defect (top, middle and
bottom) revealed different patterns in the two experimental groups
(Fig. 4C). At 6d, the highest proportion of bone was revealed at the
bottom levels of the defects in both groups (sham; 17.1 ± 2.7,
membrane; 15.8 ± 2.7), followed by the middle level (sham;
10.7 ± 3.7, membrane; 9.5 ± 2.4), while the lowest proportion was
observed at the top level. After 28d, the membrane-treated defect
showed the highest proportion at the top level (39.8 ± 4.8), fol-
lowed by the middle level (25.3 ± 4.2), while the lowest was
detected at the bottom level (19.4 ± 1.5). At 28d, in the sham defect,
the lowest bone proportion was detected at the lower level of the
defect (18.9 ± 3.0), whereas the top and middle levels showed
similar bone proportions (approximately 27.5).3.3. Gene expression analysis (qPCR) of the defect
Analyses were made of the gene expression in tissue samples
retrieved during defect preparation (baseline; BL) and the tissue
harvested from the sham and the membrane-covered defects after
3d, 6d and 28d. The targeted genes in the defect site samples were
those involved in inﬂammation, cell recruitment, bone formation
and resorption, as well as the coupling of bone remodeling.3.3.1. Gene expression of inﬂammation and cell recruitment
markers
Inﬂammatory markers: with reference to BL, the temporal
pattern of TNF-a in the membrane defect revealed a signiﬁcant 2.5-
fold increase after 3d, followed by a signiﬁcant reduction after 6d
and no major change thereafter (Fig. 5A). On the other hand, no
major change in the temporal expression of TNF-awas observed in
the sham defect. The temporal pattern of IL-6 expression for both
membrane and sham defects revealed an increase over time,
reaching the highest level at 6d (about 10-fold in comparison with
BL) (Fig. 5B). From 6d to 28d, a signiﬁcant downregulation of IL-6
was found for both groups.
When comparing the two experimental groups at each time
point, the expression level of TNF-a was about 2.5-fold, signiﬁ-
cantly higher in the membrane group compared with the sham at
3d (Fig. 5A). This switched at 6d, where the membrane defect
revealed about a 2-fold, signiﬁcantly lower expression of TNF-a
compared with the sham. Later, at 28d, no signiﬁcant difference
was observed between the two groups. With respect to IL-6
expression at 3d and 6d, no signiﬁcant differences were observed
between the two groups (Fig. 5B). At 28d, a 2-fold, signiﬁcantly
higher expression of IL-6 was found in the membrane defect
compared with sham.
Cell recruitment factors: for both groups, the temporal pattern
of MCP-1 revealed signiﬁcantly higher levels at all analyzed time
points compared with BL (Fig. 5C). A sharp increase in MCP-1
expression was detected after 3d in comparison to BL (sham 6-
fold; membrane 14.5-fold). The MCP-1 expression levels were
maintained at 6d, followed by a reduction at 28d, for both groups. A
different temporal proﬁle was observed for the CXCR4, which, for
both groups, revealed signiﬁcantly lower expression levels at 3d
and 6d comparedwith BL (Fig. 5D). From 6d to 28d, a sharp increase
was demonstrated for CXCR4, attaining a comparable level to BL in
the sham group and signiﬁcantly exceeding the level of BL in the
membrane group.
When comparing the membrane and sham groups at each time
point, a similar trendwas observed for the expression of MCP-1 and
CXCR4 (Fig. 5C, D). At 3d, both MCP-1 and CXCR4 were expressed at
higher levels (2.4-fold) in the membrane group compared with the
sham. However, this was only statistically signiﬁcant for the CXCR4.
No difference between the two groups was observed for both genes
at 6d. At 28d, both MCP-1 and CXCR4 were signiﬁcantly higher in
the membrane group compared with the sham (Fig. 5C, D).
3.3.2. Gene expression of bone formation and bone resorption
markers
Bone formation markers: the temporal changes in the bone
formation markers exhibited a comparable proﬁle in the sham and
the membrane groups (Fig. 6A, B). This was characterized by the
early downregulation of both ALP and OC at 3d compared with BL.
Whereas ALP revealed a sharp increase (peak level after 6d), fol-
lowed by a marked reduction (Fig. 7A), OC showed a gradual in-
crease over time, attaining the highest level at 28d (Fig. 6B). The
peak level of ALP at 6d signiﬁcantly exceeded the BL level, whereas
the peak level of OC at 28d was similar to the BL.
A comparison of the two experimental groups at each time point
failed to reveal any signiﬁcant differences in ALP expression
(Fig. 6A). In contrast, the expression of OC (Fig. 6B) was 17-fold and
1.5-fold signiﬁcantly higher in themembrane group comparedwith
the sham, at 3d and 28d respectively.
Bone resorption markers: the temporal pattern of the osteo-
clastic surface marker, CR, and the osteoclastic activity marker
(CatK) revealed two distinct patterns (Fig. 6C, D). The expression of
CR (Fig. 6C) was generally lower in the sham defects comparedwith
BL, whereas levels comparable to the BL were observed in the
Fig. 4. Histomorphometry analysis of bone formed in defects with or without membrane. The column graphs show the bone area percentages after 6d and 28d of healing, whereas
the schematic diagrams show the respective area of measurements. The percentage of total bone area was calculated per the total area of the defect (A). The percentage of bone area
was also calculated in different regions of the defect: central and peripheral (B), top, middle and bottom (C). The results are presented as the mean ± SEM. Statistically signiﬁcant
differences are indicated by asterisks.
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expression of CatK (Fig. 6D) revealed signiﬁcantly lower levels for
both groups at 3d compared with BL. Thereafter, CatK expression
gradually increased, for both groups, attaining the highest levels
after 28d. The peak expression of CatK at 28d was signiﬁcantly
higher than the BL in the membrane group.
When comparing the two experimental groups, the CR and CatK
expression levels were signiﬁcantly higher in the membrane groupcompared with the sham after 3d (5-fold and 2.5-fold respectively)
(Fig. 6C, D).3.3.3. Gene expression of bone remodeling coupling factors
The temporal pattern of RANKL and OPG in the sham group
showed a signiﬁcant reduction at 3d compared with BL (Fig. 7A, C).
On the other hand, in the membrane group at 3d, both RANKL and
OPG revealed levels comparable to BL (Fig. 7A, C). From 3d to 6d, for
Fig. 5. Gene expression of pro-inﬂammatory cytokines and cell recruitment chemokines. The analysis was performed on the tissue harvested from defects with or without
membrane after 3d, 6d and 28d of healing. The results are presented as the mean ± SEM. Statistically signiﬁcant differences are indicated by small letters: a ¼ signiﬁcant difference
with baseline (BL); b ¼ signiﬁcant difference with sham; c ¼ signiﬁcant difference between 3d and 6d; d ¼ signiﬁcant difference between 6d and 28d.
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OPG was detected, reaching signiﬁcantly higher levels compared
with the BL (Fig. 7A, C). From 6d to 28d, the expression levels of
RANKL and OPG were signiﬁcantly reduced, revealing levels com-
parable to the BL in the membrane group and lower than the BL in
the sham group at 28d. RANK expression (Fig. 7B) showed a similar
temporal pattern for the sham and the membrane groups. It did not
change signiﬁcantly at 3d compared with BL but increased signif-
icantly after 6d, followed by a signiﬁcant decrease thereafter
(Fig. 7B). Nomajor temporal changes were observed for the RANKL/
OPG expression ratio (Fig. 7D).
The comparative analysis at 3d revealed signiﬁcantly higher
RANKL expression in the membrane-treated defect as compared to
the sham defect (Fig. 7A). On the other hand, at 6d, both RANKL and
RANK were signiﬁcantly higher in the sham defect compared with
the membrane-treated defect (Fig. 7A, B). At 28d, no major differ-
ences were observed between the sham and membrane groups
with respect to any of the analyzed remodeling coupling genes. No
signiﬁcant differences in OPG expression and RANKL/OPG expres-
sion ratio were found between the two groups at any time point
(Fig. 7C, D).
3.3.4. Correlation analysis of genes expressed in the defect
The results of the correlation analyses of the different genes inthe defect are presented in Table 1. Several correlations were
detected, mainly at 3d and 28d, and all revealed a positive rela-
tionship. At 3d, MCP-1defect revealed signiﬁcant correlations with
the pro-inﬂammatory cytokine, TNF-adefect, the osteoclastic re-
ceptor gene, CRdefect, and the coupling gene, OPGdefect. On the other
hand, CXCR4 correlated signiﬁcantly with the osteoblastic gene,
OCdefect, and the osteoclastic gene, CatKdefect. A signiﬁcantly posi-
tive relationship was also found between the osteoblastic gene,
OCdefect, and the osteoclastic gene, CatKdefect. At this early time
point, a strong positive correlation was also detected between the
pro-inﬂammatory cytokine gene, TNF-adefect, and the osteoclastic
receptor gene, CRdefect.
At 28d, the CXCR4defect was observed in relationships with
OCdefect and CatKdefect, similar to those detected at the 3d time
point. At this late time point (28d), CXCR4defect displayed a positive
correlation with the coupling factor gene, RANKLdefect. The osteo-
blastic genes, ALPdefect and OCdefect, were found in positive re-
lationships both with one another and with the osteoclastic gene,
CatKdefect. Moreover, the OCdefect revealed signiﬁcant correlations
with the coupling genes, RANKLdefect and RANKdefect. In addition,
the CatKdefect revealed signiﬁcant correlations with the RANKLdefect
and OPGdefect.
Fig. 6. Gene expression of bone formation and resorption factors. The analysis was performed on the tissue harvested from defects with or without membrane after 3d, 6d and 28d
of healing. The results are presented as the mean ± SEM. Statistically signiﬁcant differences are indicated by small letters: a ¼ signiﬁcant difference from baseline (BL);
b ¼ signiﬁcant difference from sham; c ¼ signiﬁcant difference between 3d and 6d; d ¼ signiﬁcant difference between 6d and 28d.
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At 6d, the collagen strands of the membrane appeared to be
intact, with a relatively uniform thickness and a unidirectional
arrangement (Fig. 8A). A large population of cells was observed at
the membrane peripheries, where many of these cells appeared to
be migrating from the surrounding tissue into the membrane,
through the open spaces between the strands (Fig. 8B). The
recruited cells, around and inside themembrane, assumed different
phenotypes, with both hematopoietic (polymorphonuclear cells
and monocyte-/macrophage-like cells) and mesenchymal origins
(Fig. 8B) but with a predominance of inﬂammatory cells. After 28d
of healing, the membrane was still observed at the site of the im-
plantation (Fig. 8C, D). However, the collagen strands of the
membrane were thinner, disrupted and apparently in a random
arrangement (Fig. 8C). Furthermore, tissue and cells, surrounding
and inﬁltrating themembrane, showed a relatively higher degree of
organization and homogeneity. At this stage, polymorphonuclear
cells were seldom detected, within or in proximity to the mem-
brane. In spite of this, cells of hematopoietic origin, monocyte- or
macrophage-like cells, were observed in conjunction with stromal
cells (Fig. 8D). In addition, many osteoclast-like cells were
observed, at 28d, in connection with resorption areas on the bone
side at the boundary between themembrane and the newly formedbone (Fig. 8D).
3.5. Gene expression (qPCR) of the retrieved membrane
The gene expression of four selected growth factors was
analyzed in the retrieved membranes at 3d, 6d and 28d of healing.
The temporal expression pattern revealed a steady increase over
time for TGF-b, FGF-2 and BMP-2 (Fig. 8E, F, G). However, these
steady increases were statistically signiﬁcant for TGF-b and FGF-2
but not for BMB-2. The opposite trend was observed for VEGF
expression, where the highest expression was detected at 3d and it
steadily decreased thereafter (Fig. 8H).
3.5.1. Correlation analysis of genes expressed in the retrieved
membranes and the equivalent defects
The results of the correlation analysis of the different genes in
the membrane, as well as between the genes in the membrane and
the genes in the equivalent defects, are presented in Table 2. The
analysis was performed between the different genes after pooling
the expression levels during the entire period of GBR.
The membrane compartment showed a signiﬁcantly positive
correlation between FGF-2membrane and TGF-bmembrane. Both FGF-
2membrane and TGF-bmembrane genes exhibited a signiﬁcantly nega-
tive correlation with VEGFmembrane.
Fig. 7. Gene expression of bone remodeling coupling factors. The analysis was performed on the tissue harvested from defects with or without membrane after 3d, 6d and 28d of
healing. The results are presented as the mean ± SEM. Statistically signiﬁcant differences are indicated by small letters: a ¼ signiﬁcant difference from baseline (BL); b ¼ signiﬁcant
difference from sham; c ¼ signiﬁcant difference between 3d and 6d; d ¼ signiﬁcant difference between 6d and 28d.
Table 1
Correlation analysis of genes expressed in the defect, with and without membrane.
The data show genes that revealed signiﬁcant correlations, separately for each
healing time period (3d, 6da and 28d). Spearman correlation coefﬁcients (r) and
level of signiﬁcance (p-values) are presented.
3d 28d
Genes (r) (p) Genes (r) (p)
MCP-1defect/TNF-adefect 0.86 0.007 CXCR4defect/OCdefect 0.80 0.001
MCP-1defect/CRdefect 0.88 0.004 CXCR4defect/CatKdefect 0.73 0.01
MCP-1defect/OPGdefect 0.93 0.001 CXCR4defect/RANKLdefect 0.75 0.002
CXCR4defect/OCdefect 0.86 0.007 ALPdefect/OCdefect 0.67 0.009
CXCR4defect/CatKdefect 0.83 0.01 ALPdefect/CatKdefect 0.75 0.002
TNF-adefect/CRdefect 0.93 0.001 OCdefect/CatKdefect 0.70 0.005
OCdefect/CatKdefect 0.88 0.004 OCdefect/RANKLdefect 0.74 0.003
OCdefect/RANKdefect 0.80 0.0003
CatKdefect/RANKLdefect 0.80 0.001
CatKdefect/OPGdefect 0.80 0.001
a No signiﬁcant correlations were detected at 6d, except for one positive corre-
lation: ALPdefect/OPGdefect (r ¼ 0.73; p ¼ 0.003).
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growth factor genes in the membrane and the genes denoting cell
recruitment and differentiation in the defect. Signiﬁcantly positive
correlations were shown for TGF-bmembrane, FGF-2membrane andBMP-2membrane with OCdefect and CatKdefect. On the other hand,
VEGFmembrane revealed a signiﬁcantly negative correlation with
OCdefect and CatKdefect. Moreover, a signiﬁcantly negative correla-
tion was displayed between TGF-bmembrane and the chemotactic
gene, MCP-1defect.
3.6. Protein expression in the native and retrieved membrane
The presence of selected growth factor proteins (FGF-2 and
BMP-2) in the native and the retrieved membranes at 3d, 6d and
28d was investigated. The blot revealed a FGF-2 protein band be-
tween 17 and 20 kDa for both native and retrieved membrane. The
detected band was deeply stained at the blot sites for the retrieved
membrane samples, regardless of the retrieval time points (Fig. 8I).
The band for BMP-2, between 15 and 20 kDa, was also detected on
the blotted protein from the retrieved membranes at all retrieval
time points. In contrast, BMP-2 was not detected in the native
membrane (Fig. 8I).
The presence of BMP-2 and FGF-2 proteins, in the membrane
compartment during GBR, was also analyzed by immunohisto-
chemistry (IHC) of the membrane in situ overlying the defect.
Negative control sections (Fig. 8J, K) excluded any possible false
positive staining, and conﬁrmed the speciﬁcity of the employed
antibodies. IHC demonstrated immunoreactivity for both BMP-2
Fig. 8. Histology, gene expression and protein analyses of the membrane. The micrographs (AeD) show non-decalciﬁed toluidine blue-stained ground sections of the membrane in
place after 6d (A and B) and 28d (C and D) of healing. At 6d, the collagen strands of the membrane appeared to be more intact, with relatively uniform thickness and a unidirectional
arrangement (A). At this time point, the spaces between the membrane strands appeared to be inﬁltrated with cells from different phenotypes, including cells with an hemato-
poietic origin (polymorphonuclear and monocyte-/macrophage-like cells; some of them are indicated by black arrows in B), as well as with a mesenchymal origin (MSC- and
ﬁbroblast-like cells; some of them are indicated by red arrows in B). At 28d, the collagen strands of the membrane appeared to be more distorted, with varying thickness and a
random arrangement (C). At this time point, the spaces between the membrane strands were still inﬁltrated with cells from different phenotypes, including cells with an he-
matopoietic origin (monocyte-/macrophage-like cells; some of them are indicated by black arrows in D), as well as with a mesenchymal origin (MSC- and ﬁbroblast-like cells; some
of them are indicated by red arrows in D). Polymorphonuclear cells were seldom detected within or in the proximity of the membrane at this time point. Furthermore, many
osteoclast-like cells were evident at this time point at the boundary between the lower surface of the membrane and the newly formed bone (some of them are indicated by black
arrowheads in D). The column graphs (EeH) show the gene expression of selected growth factors TGF-b1 (E), FGF-2 (F), BMP-2 (G) and VEGF (H) in the membrane-associated cells.
The analysis was performed on the retrieved membrane after 3d, 6d and 28d of healing. The results are presented as the mean ± SEM. Statistically signiﬁcant differences between
different time points are indicated by asterisks. The image of the Western blot analysis of the membrane (I) shows the bands of FGF2 and BMP-2 proteins. The analysis was
performed on both native membrane and membrane retrieved from the defect sites after 3d, 6d and 28d of healing. Rat liver protein was used as a positive control for BMP2
antibody. The micrographs (JeO) show the immunohistochemical analysis of decalciﬁed sections of the membrane in place after 3d and 6d of healing. The micrographs show the
BMP-2 (L and N) and FGF-2 (M and O) immunoreactivity in cells and extracellularly in the membrane compartment at 3d (L and M) and 6d (N and O) of healing. The intracellular and
extracellular staining of the two proteins is exempliﬁed with white arrows and arrowheads, respectively, at the 3d time point (in L and M). The micrographs (J and K) show the 3d
negative control samples for the immunostaining of BMP-2 and FGF-2, respectively.
A. Turri et al. / Biomaterials 84 (2016) 167e183 177and FGF-2 inside the membrane at the two evaluated periods, 3d
and 6d (Fig. 8LeO). At both time points, the expression of BMP-2
and FGF-2 proteins was detected intracellularly and interstitially
in-between the strands of the collagen membrane (Fig. 8LeO).
4. Discussion
The present experimental study investigated the mechanisms of
guided bone regeneration (GBR), in trabecular bone defects, usingan extracellular matrix-derived membrane. The spatial and tem-
poral cellular and molecular events were determined, at different
time points of healing, in the defect, underneath themembrane and
in themembrane itself. The results of the study provided structural,
cellular andmolecular evidence suggesting that the membrane acts
as a bioactive compartment, rather than merely acting as a passive
barrier. The main ﬁndings can be summarized as following: ﬁrstly,
the membrane attracts cells of different phenotypes, which
sequentially express and secrete factors and signals for bone
Table 2
Correlation analysis of genes expressed in the retrieved membranes and the equivalent defect samples. The data show genes that revealed signiﬁcant correlations by pooling
the expression levels for all healing time periods (3d, 6d and 28d). Spearman correlation coefﬁcients (r) and level of signiﬁcance (p-values) are presented.
Correlations between genes in the membrane Correlation between genes in the membrane with genes in the equivalent
defects
Genes (r) (p) Genes (r) (p)
TGF-bmembrane/FGF-2membrane 0.80 0.00002 TGF-bmembrane/MCP-1defect 0.68 0.001
TGF-bmembrane/VEGFmembrane 0.80 0.00008 TGF-bmembrane/OCdefect 0.83 0.00001
TGF-bmembrane/CatKdefect 0.81 0.00002
FGF-2membrane/VEGFmembrane 0.87 0.000002 FGF-2membrane/OCdefect 0.78 0.00009
FGF-2membrane/CatKdefect 0.77 0.0001
VEGFmembrane/OCdefect 0.80 0.00004
VEGFmembrane/CatKdefect 0.73 0.0004
BMP-2membrane/OCdefect 0.76 0.0001
BMP-2membrane/CatKdefect 0.59 0.008
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vascularization (VEGF). Secondly, the membrane compartment
promotes the expression of chemotactic factors and modulates the
osteogenic and remodeling processes in the treated defect, pri-
marily underneath the membrane. Thirdly, these membrane-
induced processes result in an accelerated woven bone formation
and, during the course of healing, superior defect restitution with
bone.
4.1. Bone formation and bone remodeling in defects covered with
membrane
Histological observations revealed a higher degree of bone for-
mation, preferentially at the top level and the central region of the
defect, leading to a higher overall degree of bone restitution in the
defect. This is in contrast to a smaller amount of bone and the
relative collapse of the defect in the absence of the membrane. The
restitution with bone is in line with commonly observed clinical
outcomes of GBR, using different types of membrane in different
types of bone defect [22e25].
The present study shows that the increased bone formation is
promoted at the molecular level, whereby the presence of the
membrane signiﬁcantly induced the expression of OC, a major
osteoblastic and bone formation gene. The osteogenic activity was
conﬁrmed during both the early and late phases of healing. The
early membrane-induced upregulation most likely corresponds to
increased osteogenic differentiation and the observed early woven
bone formation. On the other hand, the late-phase effect of the
membrane on OC expression suggests the continuous process of
membrane-induced bone formation and maturation.
Topologically, and irrespective of the presence or absence of the
membrane, new bone formation was distributed in two different
patterns at early (6d) and late (28d) healing time points. At the
early time point, bone formed predominantly in the bottom and
peripheral regions of the defect, whereas the top and central re-
gions gained a signiﬁcant amount of bone in the late phase. The
membrane compartment played a major role in boosting this nat-
ural response. Firstly, the microenvironment created directly under
the membrane provided osteoinductive signals that rapidly pro-
moted bone formation at the top level of the defect. This prefer-
ential effect of the membrane-induced microenvironment on bone
formation at the top level of the defect extended to the late period
of healing. Secondly, the presence of the membrane microenvi-
ronment induced high osteoclastic activity, demonstrated by the
upregulated expression levels of the osteoclastic receptor (CR) and
osteoclastic activity marker (CatK). The ﬁnding that the membrane
provides a local environment for coupled bone formation and
resorption is further supported by the observation of the
membrane-induced upregulation of RANKL, which is a majorcoupling factor between osteoblasts and osteoclasts [26,27].
Moreover, the multiple positive correlations demonstrated be-
tween the osteoblastic and osteoclastic genes in the defect indicate
tight links between the expression activities. Due to this tight
coupling and the mutual cross-talk between osteoblasts and oste-
oclasts, it has been suggested that the activation of one arm of the
remodeling, i.e. the coordinated bone formation and resorption,
will be accompanied by the activation of the other arm [28,29].
Whether the membrane-induced effects primarily inﬂuenced the
osteoblastic or osteoclastic lineages, or both simultaneously, re-
mains to be explored.
The present evidence of the triggered coupled bone remodeling
activities, induced by themembrane as an implanted biomaterial, is
in line with recent studies of biomaterial-driven bone regeneration
processes, osseointegration and bone defect augmentation [30,31].
Titanium implants with oxidized surfaces [32] and alpha-tricalcium
phosphate granules with octacalcium phosphate surfaces [30] both
promoted higher osteoblastic, osteoclastic and coupling activities,
which, in parallel, promoted a higher degree of bone regeneration
and the integration of the respective materials in the recipient
defect sites. Hitherto, the exact roles of osteoclasts and their ac-
tivities in bone healing and restitution around biomaterials are
unknown. Recent insights suggest that the osteoclast is a major
stimulus for bone formation by different routes: (i) osteogenic
factors released from bone during active resorption and (ii) osteo-
genic factors secreted directly by osteoclasts [33e38]. Nevertheless,
others have postulated that the osteoclast-generated osteogenic
and coupling signals are not sufﬁcient to induce the osteogenic
activity and that a complementary prerequisite is the recruitment
of osteoprogenitors to the local site [39,40]. In the present study of
the mechanism of GBR, it is evident that the membrane compart-
ment offers conditions that promote high osteoclastic activity, as
well as inducing high recruitment activity for osteoprogenitors in
the defect.
4.2. Cell recruitment and inﬂammation in defects covered with
membrane
The membrane-established microenvironment was rapidly
sensed by cells within the defect, responding by upregulating
fundamental components in cell recruitment axes, MCP-1 and
CXCR4. MCP-1 is a chemokine which is majorly responsible for
monocyte trafﬁcking to the site of injury [41,42]. It has been also
implicated in the recruitment and differentiation of osteoclast
precursors at the sites of bone remodeling [43]. Mutant mice
lacking the receptors of MCP-1 displayed a reduced number and
impaired function of osteoclasts and eventually revealed delayed
fracture healing [44,45]. CXCR4 is a surface receptor expressed by
various cells, including leukocytes [46], MSCs and osteoprogenitors
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years, it has ﬁrst and foremost attracted attention as a major
element in regulating MSC migration and recruitment to bone
repair sites [48,51,52]. Bone defects in mutantmice partially lacking
CXCR4 (CXCR4þ/mice) showed reduced bone formation after 14d
[51]. In the present study, the early, membrane-induced upregu-
lation of MCP-1 and CXCR4, at 3d, corresponded to the recruitment
of different cell phenotypes. This assumption is based not only on
the fact that CXCR4 is a recruitment element expressed by different
cells but also on the early overlap between the upregulation of
CXCR4 expression and the upregulation of genes denoting inﬂam-
matory cells, osteoblasts and osteoclasts. At the late stage, the peak
of CXCR4 corresponded mainly to the peaks of OC and CatK, sug-
gesting a main involvement, at this stage, in bone maturation and
remodeling. Exploration of the correlation results further supports
the assumption that MCP-1 and CXCR4 were involved in the
recruitment of different cells at different stages. In the early healing
stage, whereas MCP-1 expression suggested an involvement in the
recruitment of inﬂammatory cells and osteoclast precursors, CXCR4
revealed a positive correlation mainly with osteoblastic and oste-
oclastic phenotypes. Correlation analysis at the late stage indicated
a strong association between CXCR4 and osteoblastic and osteo-
clastic activities. The present results thus suggest that the
membrane-induced microenvironment enhances chemotactic cues
which, in a time-speciﬁc manner, augment the recruitment of
different cells corresponding to the ongoing biological process.
These effects include the early inﬂux of inﬂammatory cells and
precursors for osteoblasts and osteoclasts, as well as the late
recruitment of these cells for bone maturation and remodeling.
In the present study, an evident histological feature in the
membrane-treated defect was the frequent appearance of giant
multinucleated and osteoclast-like cells, particularly in the zone
between the lower surface of the membrane and the upper surface
of the newly formed bone, in the top region of the defect. At his-
tological level, these osteoclast-like cells appeared to be actively
resorbing the underlying bone, but it was not possible to determine
whether these cells were also involved in a degradation process of
the membrane. The increase in CXCR4 and MCP-1 activity may play
a role in the tissue responsewithin and immediately adjacent to the
membrane material, e.g. providing cells for bone regeneration in
the defect region directly beneath the membrane (i.e. the top re-
gion of the defect) in parallel with a contribution to the degradation
process of the membrane. The ﬁrst possibility is supported by ob-
servations that a collagen pellet containing the pro-osteogenic
factor, BMP-2, enhanced the recruitment of osteoblast progenitors
and induced ectopic bone formation at the periphery of the
collagen pellet. These effects were strongly inhibited by blocking
the CXCR4 using antibodies [53]. The second possibility is in line
with earlier studies of similar membrane materials, showing the
strong upregulation of MCP-1 and macrophage inﬂammatory
protein-1 (MIP-1) [54] and the enhanced recruitment of macro-
phages, associated with a higher rate of graft remodeling [55].
Bone healing and regeneration is a complex process, consisting
of a sequence of biological events, including inﬂammation and cell
recruitment, bone formation and remodeling. Studies of bone
healing around biomaterials have demonstrated that the early
inﬂammation, which is an integral part of the healing process,
precedes and even overlaps the recruitment and differentiation of
the bone-forming and -resorbing cells [31,56]. By virtue of their
early recruitment to the site of healing and their wide secretory
proﬁle, monocytes/macrophages have been suggested as a potent
moderator of the healing events. These cells may sense the prop-
erties of the implanted material and translate and communicate
them to the neighboring cells, around the implanted material [57].
In the present study, the presence of the membrane stronglymodulated the expression of the inﬂammatory cytokines, TNF-a
and IL-6, in the healing defect. The early upregulation of TNF-a in
the membrane-treated defect suggests its engagement in the early
recruitment of mesenchymal cells and osteoprogenitors and their
subsequent differentiation into bone-forming cells. In vitro studies
have shown that recombinant TNF-a enhances the invasion ca-
pacity and proliferation of MSCs via the activation of IkB kinase
[58]. Other studies have revealed that recombinant TNF-a added to
MSCs under osteogenic culture conditions augments the expression
of BMP-2 and ALP and promotes higher mineralization via mech-
anisms that involve the activation of the NF-kB pathway [59].
Further, conditioned media containing a high level of TNF-a,
secreted by classically activated pro-inﬂammatory monocytes/
macrophages, strongly upregulate the osteogenic genotype of MSCs
cultured in normal non-osteogenic conditions [60]. The pro-
osteogenic potential of TNF-a has also been demonstrated in vivo
where the intramembranous ossiﬁcation was impaired in rats after
knocking out the receptors of TNF-a (TNFR1 and TNFR2) [61]. With
respect to osteoclasts, there is general consensus on the pro-
osteoclastic effect of TNF-a. The precise roles of the membrane-
induced TNF-a expression are not clear. Based on the present re-
sults, both osteogenic and osteoclastic differentiation may have
been affected. TNF-a and IL-6 may be required to promote the
higher remodeling of the defect at the late stage of healing [62,63].
The correlation analysis in the present study at least partially
supports a pro-osteoclastic role for TNF-a, based on the strong
correlation between TNF-a and the osteoclastic receptor, CR, at the
early stage of healing. Albeit speculative, the lack of statistical
positive or negative correlations between TNF-a and the osteo-
blastic markers could indicate that the ﬂuctuation in TNF-a
expression among the individual samples is compensated for by
other factors. It is also possible that the pro-osteogenic effect of
TNF-a, in vivo, is dependent on several factors in order to induce the
osteogenic response.
4.3. The role of inﬂammation in coupled bone remodeling during
GBR
The role of pro-inﬂammatory cytokines in osteoclast differen-
tiation has beenwell described. Cytokines, such as TNF-a and IL-1b,
strongly augment the RANK-RANKL pathway and can also directly
induce the differentiation of osteoclasts via other pathways
[64e66]. In the present study, there are four indications that the
membrane-induced TNF-a expression augmented the RANKL-
dependent osteoclastic differentiation. Firstly, RANKL upregula-
tion corresponded with the upregulated level of osteoclastic dif-
ferentiation marker, CR, at 3d, when TNF-a revealed the highest
expression level in the membrane-treated defect. Secondly, at 6d,
although the sham defect demonstrated higher levels of RANKL and
RANK, as compared to membrane defects, this did not correspond
with any upregulation of CR or CatK. Importantly, at this time point
(6d), the upregulated expression of TNF-a in the sham defect was
much less than that induced at 3d in the membrane-treated defect.
Thirdly, apart from the upregulated RANKL levels, in the membrane
at 3d and in the sham at 6d, the RANKL/OPG ratio did not show any
differences, either between the two groups or among the different
time periods. Since the RANKL/OPG ratio determines the RANKL
effect on osteoclasts, it is possible that the differences in osteo-
clastic activity (CR and CatK) were mediated via the modulation of
TNF-a. Finally, at 3d, it was only the TNF-a that showed a statisti-
cally positive correlation with the CR, suggesting an early role for
the pro-inﬂammatory cytokines in triggering osteoclastic
differentiation.
In addition to the role of pro-inﬂammatory cytokines in aug-
menting the RANKL pro-osteoclastic effect, they have been shown
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Interestingly, it was the membrane-induced expression of TNF-a,
but not IL-6, that corresponded with the upregulated expression of
RANKL. This observation is in agreement with previous in vitro data
showing that IL-1b and TNF-a, but not IL-6, stimulate RANKL
expression in human osteoblastic cells [68].
Taken together, the present and previous studies [30,32] of
biomaterial-driven bone regeneration emphasize the early and
critical involvement of osteoclastic activity and bone remodeling.
Some variation is observed in the biomaterial-induced osteoclastic
and remodeling activities. During osseointegration, titanium im-
plants with oxidized surfaces induced osteoclastic and bone
remodeling activity directly via the increase in the RANKL/OPG
expression ratio [32]. In that study, the pro-inﬂammatory cyto-
kines, TNF-a and IL-1b, did not appear to be involved in the oste-
oclastic and bone remodeling activities, since both were
signiﬁcantly downregulated at the oxidized titanium implant. This
contrasts to the present study, where the RANKL/OPG ratio was
constant, while the tuning was operated at the level of the pro-
inﬂammatory cytokines.
4.4. Cellular and molecular events in the membrane during GBR
Since the membrane promoted bone regeneration in the defect,
attention was paid to the presence of cells (demonstrated by his-
tology) and the expression of selected genes and growth-
promoting proteins in the membrane per se.
The analysis of cells in the membrane compartment demon-
strated the ability of these cells to express BMP-2, FGF-2, TGF-b1
and VEGF at the RNA level throughout the healing period. Further,
the presence of two growth factors of importance, FGF-2 and BMP-
2, was analyzed on the protein level. Whereas the existence of FGF-
2 in the native membrane was conﬁrmed, BMP-2 was not detected
in the membrane before implantation. The present results relating
to FGF-2 are in agreement with earlier studies of the membrane, as
derived from porcine small intestine submucosa [69]. Importantly,
the present WB data extends these observations, showing that the
membrane not only maintains FGF-2 after implantation and during
the constitutive phases of GBR but also accumulates the pro-
osteogenic factor, BMP-2. An important question is if BMP-2 was
mainly secreted from cells in the membrane compartment or
whether it was also adsorbed from the surrounding ﬂuids and
tissues. The observations of BMP-2 and FGF-2 immunoreactive cells
on the collagen membrane strands as well as interstitially in the
retrieved membranes, suggest that a substantial amount of the
detected growth factors are derived from active cells after
recruitment into the membrane compartment. Taken together, the
qPCR, WB and IHC data strongly support that the BMP-2 protein in
the membrane is made de novo by cells in the membrane
compartment.
Another intriguing observation was the early and strong
expression of VEGF in the membrane, with a different time course
compared with the expression of the other growth factors.
Together, these selected growth factors have potent individual and
synergistic effects on the different processes of bone healing,
including inﬂammation and cell recruitment, bone formation and
remodeling. Further studies are required in order to determine the
expression, secretion and biological effects of these factors,
particularly in relation to the properties of the membrane.
One property is the collagenous structure and composition of
the membrane, which is thought to contain cellular binding and
activation motifs, which enhance the binding, migration and acti-
vation of cells with different phenotypes [70e72]. Another prop-
erty, which is addressed in this study, is the ability of the present
ECM-derived, collagenous membrane to maintain native andin vivo accumulated growth factors. For instance, FGF-2 is well
known to stimulate the migration and proliferation of different
cells, including endothelial cells, ﬁbroblasts and osteoblasts, during
bone healing [73]. In addition, it plays a critical role in angiogenesis
and mesenchymal cell mitogenesis [73,74]. Furthermore, both FGF-
2 and BMP-2 are involved in the recruitment and formation of
osteoclasts, directly or indirectly via the increased angiogenesis and
osteogenesis [75e77]. It is therefore likely that FGF-2 and BMP-2
proteins, together with the collagenous support structure of the
membrane, are important factors in the migration, proliferation
and differentiation of different cells in the membrane. In the pre-
sent study, different cell populations could be identiﬁed inside the
membrane. For instance, at 6d, a combination of inﬂammatory
cells, ﬁbroblasts and stromal/mesenchymal-like cells was recog-
nized, whereas, at 28d, stromal cells constituted the dominant
population. With respect to the early time point (6d), the
membrane-inﬁltrated cells have recently been shown to comprise
both CD68-positive monocytes/macrophages as well as periostin-
positive osteoprogenitors [78]. Moreover, in the present study,
several blood vessels, as well as osteoclast-like cells, were observed,
particularly on the outer surface of the membrane and along the
border between the membrane and the newly formed bone.
The inward migration of the inﬂammatory cells into the mem-
brane could be also implicated in the membrane degradation, as
the ECM membrane is made of collagen and can be degraded by
cellular activities [79e81]. Macroscopically, after 28d of implanta-
tion, the retrieved membrane showed reasonable integrity, since it
was removed as one segment during the retrieval procedure.
However, distortion and derangement in the collagen strands of the
membrane were detected at histological level, suggesting a slow
degradation process. Furthermore, the osteoclast-like cells
observed at the boundary between the membrane and the newly
formed bone might have contributed to the membrane degrada-
tion, in addition to their remodeling activity on the underlying
bone.
Taken together, it is evident that the inherited properties of the
ECM membrane have synergistically contributed to the bone pro-
moting capacity of the membrane. Regarding the physicochemical
properties, although no systematic chemical and micron- and
nano-scale topographical analyses of the membrane was conduct-
ed, it is likely that the porous structure of the membrane together
with the surface features and motifs, by which cells can recognize
and bind to the membrane, play a critical role. Regarding the bio-
logical properties, it is likely that the gradual degradation of the
ECMmembrane, assisted by the speciﬁc populations of membrane-
recruited cells (e.g. macrophages and osteoclasts), is accompanied
by a slow release of membrane degradation products, which may
include both endogenous and de novo synthesized potent growth
factors. It is suggested that for the design of future GBRmembranes,
tailoring of such functionalities may provide additional cues to
enhance bone regeneration for speciﬁc clinical indications.
4.5. The role of the membrane in GBR
Based on the observation of important biological processes in-
side the membrane compartment, the question arose as to whether
these activities were related to the expression of factors in the
defect, involved in cell recruitment, inﬂammation, bone formation
and bone remodeling. Important support for the role of factors
expressed in the membrane was provided by the results of the
correlation analysis between factors in the membrane and the
defect. Firstly, the three pro-osteogenic signals (FGF-2, TGF-b1 and
BMP-2) in the membrane demonstrated a positive correlation with
the bone formation and bone resorption genes in the defect. This is
in line with the current insights suggesting that signals that
A. Turri et al. / Biomaterials 84 (2016) 167e183 181provoke one arm of the remodeling process subsequently stimulate
the other process. A collagen sponge loaded with recombinant
BMP-2 in a rat calvarial defect enhances both osteoclastogenesis
and osteoblastogenesis [82]. Furthermore, in vitro and in vivo
studies have revealed regulatory and inducing effects for FGF-2,
TGF-b and BMP-2 on the differentiation of both osteoblasts and
osteoclasts [83e87]. Secondly, the inverse relationship between
TGF-b, in the membrane, and MCP-1, in the defect, suggests a role
for TGF-b in regulating the inﬂammatory phase in the defect. TGF-b
is a multifunctional growth factor, which has dual pro-
inﬂammatory and anti-inﬂammatory effects [88]. Finally, the in-
verse correlation between VEGF in the membrane and OC and CatK
in the defect may indicate a switch in the intensities of the angio-
genic and bone remodeling activities.
4.6. Methodological considerations
One major limitation in the present study was the difﬁculty
determining the differential effect of the membrane on the cellular
and molecular activities within the defect, at different distances
from the membrane. This is based on the fact that the molecular
activities were analyzed in the entire defect site, which may mask
possible differences in speciﬁc regions of the defect. Further studies
will require site-speciﬁc analyses, employing, for example, in-situ
hybridization, or laser micro-dissection to obtain samples from
different regions of the defect for subsequent qPCR analysis. A
similar approach could also be used in a kinetic study in which the
laser sampling for qPCR is performed, site by site, in a direction
towards the membrane. The latter strategy can be employed in
parallel with histological and histomorphometric scoring of the
degree of membrane degradation, over a prolonged period of time.
This will provide essential evidence relating to whether the
membrane contributes to its own degradation, while establishing
an optimal microenvironment for bone formation and remodeling
and ultimately complete defect restitution.
5. Conclusion
The present results show and describe the sequence of biolog-
ical events during GBR, encompassing the inwardmigration of cells,
which acquire phenotypes that contribute to a pro-osteogenic and
remodeling microenvironment, primarily underneath the mem-
brane. The molecular mechanisms whereby this pro-osteogenic
and remodeling microenvironment contributes to bone regenera-
tion and defect healing involve the expression and accumulation of
pro-osteogenic factors within the membrane, which trigger the
molecular cascade for rapid, higher bone formation and remodeling
in the underlying defect. The present results provide cellular and
molecular evidence suggesting a novel role for the membrane
during GBR, by acting as a bioactive compartment rather than
merely a passive barrier. These biological ﬁndings provide an op-
portunity to intentionally tailor the composition and structure of
the membrane to enhance GBR in different bone applications.
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